Back

Methyl Carnosate, a Carnosic Acid Derivative, Attenuates Osteoclastogenesis via Modulation of RANKL-Induced NF-κB Activity

Zhang, L.; Xie, C.; Bao, X.; Tabandeh, M.; Deepak, V.

2026-01-15 pharmacology and toxicology
10.64898/2026.01.15.699687 bioRxiv
Show abstract

Excessive osteoclast activity underlies bone-destructive diseases including osteoporosis and rheumatoid arthritis. RANKL-induced NF-{kappa}B signaling represents a critical pathway driving osteoclastogenesis. Here, we report that methyl carnosate, a naturally occurring diterpene from rosemary, inhibits RANKL-induced osteoclastogenesis with an IC50 of 1.2 M and displays greater potency than its parent compound, carnosic acid. Promoter-reporter analysis further indicates attenuation of RANKL-induced NF-{kappa}B activity. These findings identify methyl carnosate as a potential lead compound for the development of bone-protective therapeutics.

Published in Frontiers in Pharmacology (predicted rank #3) · training set

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.